Variant report
Variant | nsv1031885 |
---|---|
Chromosome Location | chr7:124236838-124268655 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:5)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:5 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr7:124241436..124243919-chr7:124287196..124289609,2 | K562 | blood: | |
2 | chr7:124244631..124246147-chr7:124248591..124250431,2 | K562 | blood: | |
3 | chr7:124235889..124237872-chr7:124241238..124243364,2 | K562 | blood: | |
4 | chr7:124235889..124237872-chr7:124241238..124243364,2 | K562 | blood: | |
5 | chr7:124244631..124246147-chr7:124248591..124250431,2 | K562 | blood: |
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
ENSG00000207214 | chromatin interactions |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs141889992 | chr7:124237083-124237084 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs7341514 | chr7:124237115-124237116 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs10954042 | chr7:124237138-124237139 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
4 | rs1524756 | chr7:124237196-124237197 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
5 | rs548149156 | chr7:124237206-124237207 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs185275370 | chr7:124237226-124237227 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs115998016 | chr7:124237251-124237252 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs147084565 | chr7:124237252-124237253 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs569918696 | chr7:124237352-124237353 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs138450902 | chr7:124237378-124237379 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs565847757 | chr7:124237448-124237449 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs371419030 | chr7:124237451-124237452 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs1524757 | chr7:124237467-124237468 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
14 | rs534504331 | chr7:124237494-124237495 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs557793058 | chr7:124237511-124237512 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs577851176 | chr7:124237520-124237521 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs1524758 | chr7:124237543-124237544 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
18 | rs368877754 | chr7:124237560-124237561 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs556938132 | chr7:124237578-124237579 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs78118486 | chr7:124237611-124237612 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs542753472 | chr7:124237617-124237618 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs144016738 | chr7:124237626-124237627 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs143054682 | chr7:124237637-124237638 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs556986160 | chr7:124237663-124237664 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs6975677 | chr7:124237668-124237669 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
26 | rs564661827 | chr7:124237679-124237680 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs533695021 | chr7:124237711-124237712 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs189088824 | chr7:124237770-124237771 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs563706023 | chr7:124237785-124237786 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs529211698 | chr7:124237797-124237798 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs549109718 | chr7:124237848-124237849 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs565811456 | chr7:124237849-124237850 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs559152226 | chr7:124237891-124237892 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs534539111 | chr7:124237893-124237894 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs181122453 | chr7:124237928-124237929 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs571324047 | chr7:124237957-124237958 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs148230848 | chr7:124237973-124237974 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs375036790 | chr7:124237977-124237978 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs77770207 | chr7:124241449-124241450 | Inactive region | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
40 | rs547440880 | chr7:124241456-124241457 | Inactive region | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
41 | rs76182228 | chr7:124241468-124241469 | Inactive region | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
42 | rs560737798 | chr7:124241472-124241473 | Inactive region | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
43 | rs539206487 | chr7:124241598-124241599 | Inactive region | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
44 | rs552620887 | chr7:124241599-124241600 | Inactive region | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
45 | rs569565349 | chr7:124241615-124241616 | Inactive region | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
46 | rs558794797 | chr7:124241621-124241622 | Inactive region | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
47 | rs532607227 | chr7:124241623-124241624 | Inactive region | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
48 | rs373724114 | chr7:124241630-124241631 | Inactive region | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
49 | rs574860942 | chr7:124241687-124241688 | Inactive region | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
50 | rs552777974 | chr7:124241809-124241810 | Inactive region | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Esophageal squamous carcinoma | 21637470 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Seminomas | 18059402 | CNVD |
Testicular cancer | 18059402 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Autism | 19415332 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Pleomorphic xanthoastrocytoma | 20730472 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
Malaria | 21533027 | CNVD |
Melanoma | 18172304 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
head and neck squamous cell carcinoma | 19289630 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Autism | 22495311 | CNVD |
Wilms tumour | 21544195 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Squamous cell cancer | 21044232 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Astrocytoma | 17387387 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Low-grade fibromyxoid sarcoma | 0 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Breast cancer | 21264507 | CNVD |
Shwachman-Diamond syndrome | 22934832 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Cutaneous malignant melanoma | 17690212 | CNVD |
Leukemia | 17361228 | CNVD |
Breast cancer | 16461572 | CNVD |
Peripheral t-cell lymphoma | 19118030 | CNVD |
Malignant melanoma | 17690212 | CNVD |
Renal cell carcinoma | 18592004 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
abortions and stillbirths | 19751515 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Lung cancer | 18438408 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Non-syndromic sensorineural hearing loss | 21987784 | CNVD |
Burkitt''s lymphoma | 19759907 | CNVD |
Myelodysplastic syndrome | 21251322 | CNVD |
Chronic myeloid leukemia | 21384125 | CNVD |
Breast cancer | 21858162 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Prostate cancer | 16573809 | CNVD |
Medulloblastoma | 16783165 | CNVD |
Biliary cancer | 19435499 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Ovarian neoplasms | 16753589 | CNVD |
Prostate cancer | 23792589 | CNVD |
Adenocarcinoma | 21044232 | CNVD |
Splenic marginal zone lymphoma | 21957467 | CNVD |
Non-small cell lung cancer | 19889201 | CNVD |
Acute myeloid leukemia | 18000384 | CNVD |
Esophageal adenocarcinoma | 18820669 | CNVD |
Metastatic melanoma | 18483359 | CNVD |
Autism | 18414403 | CNVD |
Autism | 19401682 | CNVD |
Autism | 19546859 | CNVD |
Schizophrenia | 19546859 | CNVD |
Tourette syndrome | 19546859 | CNVD |
Melanoma | 19188590 | CNVD |
Hepatocellular carcinoma | 16785998 | CNVD |
Glioblastoma multiforme | 18628472 | CNVD |
Basal cell lymphoma | 21115979 | CNVD |
Breast cancer | 21509527 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Epilepsy | 21635232 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Diffuse large b-cell lymphoma | 18287131 | CNVD |
abnormal development | 18461090 | CNVD |
T-cell acute lymphoblastic leukemia | 18185524 | CNVD |
Melanoma | 20877625 | CNVD |
Breast cancer | 22522925 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr7:124237000-124237600 | Enhancers | H9 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
2 | chr7:124237000-124237800 | Enhancers | H9 Derived Neuron Cultured Cells | ES cell derived |
3 | chr7:124237000-124238000 | Enhancers | hESC Derived CD56+ Ectoderm Cultured Cells | ES cell derived |
4 | chr7:124242600-124243400 | Enhancers | Foreskin Keratinocyte Primary Cells skin02 | Skin |
5 | chr7:124242800-124243400 | Enhancers | Foreskin Keratinocyte Primary Cells skin03 | Skin |
6 | chr7:124242800-124243400 | Enhancers | Foreskin Melanocyte Primary Cells skin03 | Skin |
7 | chr7:124258600-124259400 | Enhancers | H1 Derived Mesenchymal Stem Cells | ES cell derived |
8 | chr7:124267800-124268600 | Enhancers | Foreskin Melanocyte Primary Cells skin03 | Skin |
9 | chr7:124268600-124270000 | Weak transcription | Foreskin Melanocyte Primary Cells skin03 | Skin |